Aduro Biotech
ADRO
#8311
Rank
โ‚ฌ0.20 B
Marketcap
12,38ย โ‚ฌ
Share price
4.18%
Change (1 day)
N/A
Change (1 year)

Revenue for Aduro Biotech (ADRO)

Revenue in 2020 (TTM): โ‚ฌ25.25 Million

According to Aduro Biotech's latest financial reports the company's current revenue is โ‚ฌ23.69 Million. In 2019 the company made a revenue of โ‚ฌ14.62 Million an increase over the revenue in the year 2018 that were of โ‚ฌ12.78 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aduro Biotech from 2014 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ25.25 M72.65%
2019โ‚ฌ14.62 M14.39%
2018โ‚ฌ12.78 M-12.48%
2017โ‚ฌ14.61 M-65.99%
2016โ‚ฌ42.96 M-30.55%
2015โ‚ฌ61.86 M445.07%
2014โ‚ฌ11.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ2.04 B 8,533.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ0.60 B 2,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ70.84 M 198.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚ฌ0.81 M-96.56%๐Ÿ‡ฉ๐Ÿ‡ช Germany